TABLE 4.
Prevalence of serum antibody to rMXV by age and sex in healthy adults from three Southeast Asian countries
| Country | No. positivea/no. tested (%)
|
|||||
|---|---|---|---|---|---|---|
| 20–29 yr old | 30–39 yr old | 40–49 yr old | Males | Females | Total | |
| Singapore | 22/30 (73) | 19/20 (95) | — | 41/50 (82) | — | 41/50 (82) |
| Indonesia | 43/49 (88) | 1/1 (100) | — | 21/25 (84) | 23/25 (92) | 44/50 (88) |
| Papua New Guinea | 24/27 (89) | 17/19 (89) | 2/4 (50) | 13/18 (72) | 30/32 (94) | 43/50 (86) |
| Total | 89/106 (84) | 37/40 (93) | 2/4 (50) | 75/93 (81) | 53/57 (93) | 128/150 (85) |
a
Serum samples with >50% inhibition of the A492 in the rMXV ELISA were considered positive for antibody to MXV. —, no sera available.